top of page
iPharmaCenter
News | Blogs | Healthcare | Consulting
Contact:
info@ipharmacenter.com
Home
Pharma
North America
US FDA Approvals
Canada Drug Healthcare News
APAC
China Drug Approvals
India Drug Approvals
APAC - Drug Approvals
Japan Drug Approvals | Healthcare
Europe
EMA News
LACAM
Brazil - Drug approvals
Healthcare News
US Healthcare News
US Payer News
APAC - Healthcare News
Europe Healthcare News
Lacam Healthcare News
Healthcare Policies
Disease News
Immunology
Oncology
Infections_Vaccines
Cardiovascular
Kidney Diseases
Metabolic Diseases
Women Health
Neurology
Conferences
Others
COVID-19
Contact
Germany G-BA Assessment Outcomes
Rephrase with Ginger (Cmd+⌥+E)
Conference on Retroviruses and Opportunistic Infections (CROI 2025) | San Francisco | iPharmaCenter
ViiV Healthcare’s Experimental Antibody N6LS Shows Promise in Long-Acting HIV Treatment A new study from ViiV Healthcare has demonstrated...
AstraZeneca Secures CDSCO Approval for Durvalumab in Limited-Stage Small Cell Lung Cancer Treatment | iPharmaCenter
AstraZeneca has received approval from the Central Drugs Standard Control Organisation (CDSCO) for the import, sale, and distribution of...
American Academy of Dermatology (AAD) Annual Meeting | 2025 | News | Updates | iPharmaCenter
Bimzelx (bimekizumab) Demonstrates Long-Term Skin Clearance in Moderate-to-Severe Plaque Psoriasis UCB has shared extended findings from...
bottom of page